Hosted on MSN1y
Medtronic reveal 12-month study data for DTM SCS therapy
The study, an on-label, prospective, multi-centre trial dubbed NOVA ... surgery and trialled the DTM SCS system against conventional spinal cord stimulation. Medtronic said that the study met ...
Endovascular Today13d
Medtronic’s VenaSeal Closure Compared to Surgical Stripping in 6-Month Data
Secondary outcomes through 6 months were reported from the VenaSeal Spectrum Surgical Stripping study, a randomized ...
GlobalData on MSN17h
Tivic hits enrolment target for vagus nerve stimulation trial
Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) ...
medtechdive3d
Boston Scientific resumes PFA trial in new patient group after pausing enrollment
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
Yahoo Finance23d
Medtronic’s Prevail DCB pivotal trial receives FDA IDE approval
Medtronic has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to commence a pivotal clinical trial for its Prevail coronary paclitaxel drug ...
clinicalpainadvisor.com2d
Does Dural Substitute Confetti Technique Optimize Implantation of SCS Systems?
Utilizing the Dural Substitute Confetti technique during spinal cord stimulation trial implantation may reduce complications and shorten surgery time.
Medscape26d
ICD and Neuromodulation Devices
In 2003, he underwent implantation of a SCS (Itrel III Model 7425, Medtronic Inc., Minneapolis, MN, USA) connected to a quadripolar percutaneous epidural lead (Model 3890, Medtronic) to treat drug ...